Hinge Health
HNGE
105.78
-2.32
-2.15%
Hinge Health
US · HNGE
#1682 by market cap
Listed 2025
105.78
-2.32
-2.15%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
Recent news
-
Rating change
BofA Securities Initiates Hinge Health(HNGE.US) With Buy Rating, Announces Target Price $110Market Newswire · 2026/9/29
-
Rating change
Analysts Offer Insights on Healthcare Companies: Ascendis Pharma (ASND), Argenx Se (ARGX) and Hinge Health, Inc. Class A (HNGE)TipRanks · 2026/10/12
-
Rating change
Truist Financial Initiates Hinge Health(HNGE.US) With Buy RatingMarket Newswire · 2026/9/28
-
Rating change
KeyBanc Maintains Hinge Health(HNGE.US) With Buy Rating, Raises Target Price to $140Market Newswire · 2026/10/16
-
Rating change
Stifel Maintains Hinge Health(HNGE.US) With Buy Rating, Maintains Target Price $130Market Newswire · 2026/10/30
-
Rating change
RBC Capital Maintains Hinge Health(HNGE.US) With Buy Rating, Maintains Target Price $110Market Newswire · 2026/10/17
-
Rating change
Hinge Health, Inc. Class A (HNGE) Receives a Buy From RBC CapitalTipRanks · 2026/10/17
-
Rating change
Barclays Maintains Hinge Health(HNGE.US) With Buy Rating, Raises Target Price to $110Market Newswire · 2026/10/12
-
Rating change
Wells Fargo Maintains Hinge Health(HNGE.US) With Buy Rating, Raises Target Price to $132Market Newswire · 2026/11/3
-
Rating change
Stifel Maintains Hinge Health(HNGE.US) With Buy Rating, Raises Target Price to $130Market Newswire · 2026/10/26
-
Hinge Health(HNGE.US) Officer Sells US$4.37 Million in Common StockMarket Newswire · 2026/11/13
-
Rating change
Analysts Offer Insights on Healthcare Companies: Tilray (TLRY) and Hinge Health, Inc. Class A (HNGE)TipRanks · 2026/10/12
-
Rating change
William Blair Maintains Hinge Health(HNGE.US) With Buy RatingMarket Newswire · 2026/11/5
-
Form 144 | Hinge Health(HNGE.US) Director Proposes to Sell 24.65 Million in Common StocksMarket Newswire · 2026/11/12
-
Rating change
Morgan Stanley Maintains Hinge Health(HNGE.US) With Buy Rating, Maintains Target Price $117Market Newswire · 2026/10/12
-
Rating change
Stifel Maintains Hinge Health(HNGE.US) With Buy Rating, Maintains Target Price $135Market Newswire · 2026/11/10
-
Form 144 | Hinge Health(HNGE.US) Officer Proposes to Sell 4.39 Million in Common StocksMarket Newswire · 2026/11/11
-
Rating change
BofA Securities Maintains Hinge Health(HNGE.US) With Buy Rating, Raises Target Price to $130Market Newswire · 2026/10/23
-
A Quick Look at Today's Ratings for Hinge Health(HNGE.US), With a Forecast Between $131 to $138Market Newswire · 2026/11/4
-
Hinge Health(HNGE.US) Director Sells US$24.48 Million in Common StockMarket Newswire · 2026/11/13
-
Rating change
Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE) and Precision BioSciences (DTIL)TipRanks · 2026/9/28
-
Rating change
Analysts Offer Insights on Healthcare Companies: Hinge Health, Inc. Class A (HNGE) and Agilon Health (AGL)TipRanks · 2026/9/28
-
Rating change
Analysts Have Conflicting Sentiments on These Healthcare Companies: Hinge Health, Inc. Class A (HNGE) and DaVita (DVA)TipRanks · 2026/8/5
-
Rating change
Truist Financial Maintains Hinge Health(HNGE.US) With Buy Rating, Announces Target Price $112Market Newswire · 2026/8/11
-
Rating change
Morgan Stanley Maintains Hinge Health(HNGE.US) With Buy Rating, Raises Target Price to $117Market Newswire · 2026/8/5
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-11-20 20:02:33 · For reference only, not investment advice and not tailored to your situation.
Hinge Health discussion 0 comments